5-Hydroxytryptamine and the pathophysiology of migraine

Journal of Neurology
P P Humphrey

Abstract

5-Hydroxytryptamine (5-HT; serotonin) has long been implicated in the aetiology of migraine but the evidence remains circumstantial and certainly not definitive. Numerous papers have reviewed the background which is briefly outlined here. Although the continued belief in the primary involvement of 5-HT in the genesis of a migraine attack has recently been questioned, many antimigraine drugs undeniably interact potently with 5-HT receptors. It can be argued, however, that their modest clinical benefit results from their pharmacological effects, be they mediated through 5-HT receptors or otherwise, independently of any pathophysiological involvement of endogenous 5-HT. Nevertheless, there seems convincing evidence that central release of 5-HT by various drug mechanisms causes migraine-like headache in migraineurs. It remains to be seen whether these drugs mimic the pathological event initiating the spontaneous migraine attack. Regardless of these considerations, the focus of research on 5-HT and migraine has proved to be enormously profitable over several decades, culminating recently in the identification of a novel, potentially important, antimigraine drug for the treatment of the acute attack. This drug, sumatriptan, is a sele...Continue Reading

References

May 1, 1975·The Journal of Pharmacy and Pharmacology·J R Fozard
Nov 1, 1978·Stroke; a Journal of Cerebral Circulation·V HachinskiP W Cooper
Jan 1, 1991·Journal of Neurology·W FeniukE T Whalley
Jan 1, 1990·Headache·S J Peroutka
Jan 1, 1991·Journal of Neurology·E J Mylecharane
Jan 1, 1991·Journal of Neurology·M D Ferrari
Jan 1, 1990·Annals of the New York Academy of Sciences·P P HumphreyE T Whalley
Apr 1, 1990·Stroke; a Journal of Cerebral Circulation·F T NicholsW J Michelsen
Sep 1, 1989·Neurology·M D FerrariG W Bruyn
Jan 1, 1989·British Journal of Pharmacology·W FeniukM J Perren
Apr 12, 1989·European Journal of Pharmacology·S J Peroutka, B G McCarthy
Aug 1, 1989·Trends in Pharmacological Sciences·J R Fozard, J A Gray
Aug 1, 1988·British Journal of Pharmacology·P P HumphreyD Butina
Sep 28, 1985·Lancet·J N Blau, F Solomon
Mar 1, 1988·Trends in Pharmacological Sciences·D Hoyer
Jun 28, 1986·British Medical Journal·M A DelargyA A Burt
Nov 1, 1987·Acta Psychiatrica Scandinavica·J M BouchardR Ropert
Jun 1, 1988·Clinical Pharmacology and Therapeutics·T D BrewertonD C Jimerson
Aug 1, 1973·Journal of Neurology, Neurosurgery, and Psychiatry·J D Gomersall, A Stuart
May 1, 1967·Archives of Neurology·M AnthonyJ W Lance
Feb 1, 1966·Journal of Neurology, Neurosurgery, and Psychiatry·G CurzonB Phillips
Aug 1, 1982·The Journal of Pharmacy and Pharmacology·P P HumphreyA D Watts
Aug 1, 1984·Annals of Neurology·M A Moskowitz
Oct 9, 1982·British Medical Journal·J M SommervilleJ M Watson
May 1, 1984·Biochemical Pharmacology·D J Pettibone, M Williams
Jan 1, 1983·Annals of Neurology·P D Drummond, J W Lance
Jan 1, 1981·Annual Review of Pharmacology and Toxicology·N H Raskin
Sep 1, 1981·Cephalalgia : an International Journal of Headache·J N Blau, S L Dexter
Jul 1, 1954·Physiological Reviews·I H PAGE
Oct 1, 1964·Journal of Neurology, Neurosurgery, and Psychiatry·D A CURRAN, J W Lance
Aug 1, 1955·A.M.A. Archives of Neurology and Psychiatry·A M OSTFELD, H G WOLFF
Feb 1, 1960·Neurology·R W KIMBALLE VALLEJO
Jan 1, 1959·International Archives of Allergy and Applied Immunology·F SICUTERI

Citations

Sep 19, 2001·Current Pain and Headache Reports·J F Rothrock
Nov 27, 2010·Current Treatment Options in Neurology·Teshamae S Monteith, P J Goadsby
Jul 1, 1991·Trends in Cardiovascular Medicine·H E ConnorW Feniuk
Aug 23, 2002·Pharmacology & Therapeutics·Paul L Durham, Andrew F Russo
Mar 30, 2001·Neuroscience Letters·J A TerrónE Hamel
Oct 1, 1993·Australian and New Zealand Journal of Medicine·J SiderovG Fabinyi
Nov 1, 2007·Cephalalgia : an International Journal of Headache·E Hamel
Nov 26, 1998·The British Journal of Ophthalmology·C W StorimansJ A Oosterhuis
May 1, 1994·Journal of Neurology, Neurosurgery, and Psychiatry·G D'AndreaK M Welch
Feb 24, 2001·Journal of Clinical Pharmacology·M L ChristensenL J Hak
May 27, 2014·The International Journal of Cardiovascular Imaging·Ezgi KalaycıoğluSükrü Celik
Jun 7, 2011·Journal of Neural Transmission·Arpád PárdutzLászló Vécsei
Jan 1, 1991·Journal of Neurology·W FeniukE T Whalley
Jan 1, 1991·Journal of Neurology·M D Ferrari
Jul 13, 2006·Expert Review of Neurotherapeutics·Domenico D'AmicoGennaro Bussone
Mar 8, 2011·Expert Review of Neurotherapeutics·Leslie Kelman
Nov 22, 2007·Expert Opinion on Drug Metabolism & Toxicology·B Lee Peterlin, Alan M Rapoport
Oct 26, 2011·Drug Development and Industrial Pharmacy·Azza A Mahmoud, Salwa Salah
Feb 24, 2007·European Journal of Pharmacology·J A Terrón, Esther Martínez-García
Sep 17, 2008·Headache·Geoffrey A Lambert, Alessandro S Zagami
Sep 20, 2005·Journal of Pharmacological and Toxicological Methods·Scott R ArmstrongDavid T Beattie
Jul 3, 2013·Expert Opinion on Pharmacotherapy·Martha B Ramírez RosasAntoinette Maassen Vandenbrink
Dec 2, 2011·Drug and Alcohol Dependence·Matthew W JohnsonRoland R Griffiths
Jan 20, 2017·Expert Opinion on Investigational Drugs·Piero BarbantiR Palmirotta
Mar 26, 2016·Cephalalgia : an International Journal of Headache·Marie DeenMessoud Ashina
Oct 22, 2014·Cephalalgia : an International Journal of Headache·Andrej FabjanMarjan Zaletel
May 1, 1992·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·H E ConnorP P Humphrey
Jun 1, 1993·Cephalalgia : an International Journal of Headache·M D Ferrari, P R Saxena
Jun 1, 1993·Cephalalgia : an International Journal of Headache·V K Gupta
Dec 1, 1993·Cephalalgia : an International Journal of Headache·A PanconesiB Tarquini
Apr 1, 1996·Cephalalgia : an International Journal of Headache·N R CutlerS A Reines
Oct 1, 1996·Cephalalgia : an International Journal of Headache·A Srikiatkhachorn, M Anthony
Nov 14, 1997·Cephalalgia : an International Journal of Headache·H GijsmanM D Ferrari
Oct 12, 2001·Cephalalgia : an International Journal of Headache·B Gomez-MancillaD E Blunt
Sep 11, 2012·Acupuncture in Medicine : Journal of the British Medical Acupuncture Society·Eliane Cristina FerroJosie Resende Torres Silva
Apr 12, 2005·Journal of Cardiovascular Pharmacology·Angelica WackenforsMalin Malmsjö
Feb 7, 2020·Neurological Research·Nermin TanikLevent Ertugrul Inan
May 19, 2016·Oncotarget·Marta KowalskaJolanta Dorszewska
Feb 7, 1998·Cephalalgia : an International Journal of Headache·D A MarcusL M Gourley
Sep 10, 2020·Brain Sciences·Luigi Vetri
May 5, 2018·Current Pain and Headache Reports·Tal Eidlitz Markus, Irene Toldo

Related Concepts

Cerebrovascular Occlusion
Status Migrainosus
Hydroxytryptamine

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Neural Activity: Imaging

Imaging of neural activity in vivo has developed rapidly recently with the advancement of fluorescence microscopy, including new applications using miniaturized microscopes (miniscopes). This feed follows the progress in this growing field.

The Tendon Seed Network

Tendons are rich in the extracellular matrix and are abundant throughout the body providing essential roles including structure and mobility. The transcriptome of tendons is being compiled to understand the micro-anatomical functioning of tendons. Discover the latest research pertaining to the Tendon Seed Network here.

Myocardial Stunning

Myocardial stunning is a mechanical dysfunction that persists after reperfusion of previously ischemic tissue in the absence of irreversible damage including myocardial necrosis. Here is the latest research.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Incretins

Incretins are metabolic hormones that stimulate a decrease in glucose levels in the blood and they have been implicated in glycemic regulation in the remission phase of type 1 diabetes. Here is the latest research.

Chromatin Regulation and Circadian Clocks

The circadian clock plays an important role in regulating transcriptional dynamics through changes in chromatin folding and remodelling. Discover the latest research on Chromatin Regulation and Circadian Clocks here.

Long COVID-19

“Long Covid-19” describes illness in patients who are reporting long-lasting effects of the SARS-CoV-19 infection, often long after they have recovered from acute Covid-19. Ongoing health issues often reported include low exercise tolerance and breathing difficulties, chronic tiredness, and mental health problems such as post-traumatic stress disorder and depression. This feed follows the latest research into Long Covid.

Spatio-Temporal Regulation of DNA Repair

DNA repair is a complex process regulated by several different classes of enzymes, including ligases, endonucleases, and polymerases. This feed focuses on the spatial and temporal regulation that accompanies DNA damage signaling and repair enzymes and processes.

Related Papers

Cephalalgia : an International Journal of Headache
M D Ferrari, P R Saxena
Journal of Neurology
P R Saxena, M O Den Boer
© 2021 Meta ULC. All rights reserved